T2. Studies of empiric and pre-emptive therapy
Poster Session: Transplant and Immunocompromised Host Infections
Johan A. Maertens, MD PhD
Professor
UZ Leuven
Leuven, Vlaams-Brabant, Belgium
Shariq Haider, MD, FRCPC, FACP, CCST
Juravinski Hospital and Cancer Center
Hamilton, Ontario, Canada
Matthew Cheng, MD
Assistant Professor
McGill University Health Centre
Montreal, Quebec, Canada
Avichai Shimoni, MD
Chaim Sheba Medical Center
Ramat Gan, Tel Aviv, Israel
Ilaria Albieri, PhD
Takeda Pharmaceuticals International AG
Zürich, Zurich, Switzerland
François Gavini, MSc
Takeda Pharmaceuticals International AG
Zürich, Zurich, Switzerland
Tien Bo, PharmD
Global Medical Lead
Takeda Development Center Americas, Inc.
Lexington, MA, United States
Irmgard Andresen, MD
Takeda Pharmaceuticals International AG
Zürich, Zurich, Switzerland